Global Aneroid Sphygmomanometer Market – Industry Trends and Forecast to 2029

Global Aneroid Sphygmomanometer Market, By Product (Electronic Sphygmomanometer, Aneroid Sphygmomanometer and Mercury Sphygmomanometer), Application (Hospital, Clinic, Family and Other) – Industry Trends and Forecast to 2029

Aneroid Sphygmomanometer Market Analysis and Size

The aneroid sphygmomanometer market is expected to witness significant growth during the forecast period. The demand for sphygmomanometers is increasing as the number of healthcare professionals and institutions around the world in need of basic diagnostic equipment increases. The prevalence of cardiovascular diseases such as hypertension is increasing. Coupled with this, an increase in the average number of patient visits and an increase in the elderly population will also drive market growth. A sphygmomanometer is a medical device that measures a patient's arterial blood pressure. It is considered safe because it does not contain mercury.

Data Bridge Market Research analyses a growth rate in the global aneroid sphygmomanometer market in the forecast period 2022-2029. The expected CAGR of global aneroid sphygmomanometer market is tend to be around 9.87% in the forecast period of 2022 to 2029. The market was valued at USD 1.81 billion in 2021, and it would grow upto USD 3.84 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Aneroid sphygmomanometers are widely used to measure blood pressure indirectly, despite great concerns about their accuracy. Mercury sphygmomanometers are very accurate, but there are concerns about the environmental toxicity of mercury. The increasing number of medical facilities and specialists around the world in need of primary diagnostic equipment has increased the demand and acceptance of blood pressure monitors.

Aneroid Sphygmomanometer Market Scope and Segmentation

Global Aneroid Sphygmomanometer Market Dynamics

Drivers

• Increasing acceptance of digital blood pressure monitors

The market size of global aneroid sphygmomanometer is estimated to exceed 11.4% by 2026. Compared to other manual blood pressure monitors, these devices are easy to use, mercury free, accurate and especially automatic. The digital sphygmomanometer is very user-friendly and can be used by the general public at home. Therefore, the multiple benefits of aneroid sphygmomanometer, increased awareness of people's health, and the growth of innovation drive market growth.

• Accuracy of manual sphygmomanometers

Manual blood pressure monitors provide more accurate readings compared to other devices. They also help confirm the patient's diagnosis of hypertension. According to recent research, high blood pressure is a major burden around the world, with mortality rates of about 13% to 14%. Sphygmomanometers provide accurate blood pressure measurements and early diagnosis, preventing additional serious health conditions that can lead to death.

Opportunities

• Increase in healthcare professionals

Today, almost all doctors or nurses use sphygmomanometers to treat patients. According to a recent article published by Athena Health, the total number of doctors in the United States has increased by about 150% over the last few decades. This increase in the number of doctors has increased the demand and acceptance of basic diagnostic equipment, including blood pressure monitors.

Restraints/Challenges

• Lack of skilled professionals

The lack of qualified personnel who are unable to use these tools could curb the growth of the  aneroid sphygmomanometer market over a forecast period.

• High Cost

High cost of these machines can hinder the growth of the global aneroid sphygmomanometer market even though the prevalence of the diseases are high.

This global aneroid sphygmomanometer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global aneroid sphygmomanometer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Market Developments

• In January 2020, Spengler and Holtex joined forces to form a leading medical device company. The merger is expected to expand the sales and distribution network and expand the company's business profits.

Global Aneroid Sphygmomanometer Market Scope

The global aneroid sphygmomanometer market is segmented on the basis of type, technology, image and indications. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Electronic Sphygmomanometer
• Aneroid Sphygmomanometer
• Mercury Sphygmomanometer

Application

• Hospital
• Clinic
• Family
• Other

Aneroid Sphygmomanometer Market Regional Analysis/Insights

The global aneroid sphygmomanometer market is analysed and market size insights and trends are provided by type, technology, image and indications as referenced above.

The major countries covered in the global aneroid sphygmomanometer market are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is the dominating region in the global aneroid sphygmomanometer market due to the availability of technologically advanced equipment and the increasing prevalence of chronic illnesses.

Meanwhile, the Asia-Pacific region has shown significant growth in the global aneroid sphygmomanometer market during the forecast period due to increasing healthcare facilities and growing elderly population in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Aneroid Sphygmomanometer Market Share Analysis

The global aneroid sphygmomanometer market market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to budesonide inhaler system market.

Key players operating in the global aneroid sphygmomanometer market include:

• A & D Company (India)
• Welch Allyn (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• General Electric (U.S.)
• Omron (Japan)
• Beurer GmbH (Germany)
• Paul Hartmann AG (Germany)
• Microlife Corporation (Switzerland)
• American Diagnostic (U.S.)
• Rossmax International (Japan)
• Rudolf Riester GmbH (Germany)
• Briggs Healthcare (U.S.)
• Terumo Corporation (Japan)